Glossary of Terms

Acute pain - sudden, severe pain from a specific cause (injury, infection, inflammation, etc) that lasts a limited time (as opposed to chronic pain).

• Agonist - a compound that will bind to a receptor to form a complex which elicits a full pharmacological response, peculiar to the nature of the receptor involved.

• Antagonist - a compound that will bind to a receptor to form a complex which does not give rise to any response, as if the receptor were unoccupied.

• Delta receptors - a term used collectively to refer to two characterized subtypes of opioid receptors (delta-1, delta-2) that possess numerous features in common which are not present in the mu receptors or kappa receptors.

• Dynorphin - an endogenous peptide which functions as a selective agonist for the kappa opioid receptors.

• Endorphin(s), beta-endorphin - an endogenous peptide which functions as a selective agonist for the mu-opioid receptors.

• Endomorphin - a term which refers to two small (5 amino-acids) endogenous peptides, known as endomorphin-1 and endomorphin-2, which function as mu-agonists with greater selectivity than beta-endorphin.

• Enkephalin - one of a number of endogenous peptides which function as selective agonists for the delta-opioid receptors.

• Full agonist - see "agonist"

• Inverse agonist - in the context of receptors which exert some basic signaling activity even the absence of an agonist (characteristic known as "constitutive activity"), an agent which binds to a receptor, suppressing this activity to some degree.

• Intrinsic activity - a measure of the maximum response to an agonist.

• Kappa receptors - a term used collectively to refer to three characterized subtypes of opioid receptors (kappa-1, kappa-2, kappa-3) that possess numerous features in common which are not present in the mu receptors or delta receptors.

• Ligand - molecule which binds to a receptor to form a complex.

• MAO inhibitors—monoamine oxidase inhibitors are prescription medications that block the action of monoamine oxidase in the brain. They relieve certain types of mood disorders such as depression, phobias, anxiety, and panic attacks.
  
• Narcotic - literally "sleep/stupor-inducing agent". Term usually applied indiscriminately to describe any exogenous compound with a "sedating" profile. Use of the term with reference to the opioids is not recommended, due to its ambiguity, and arguably negative connotation.

• Neurotransmitter - any endogenous compound that plays a role in synaptic nervous transmission.

• Opiate - compound containing the fundamental morphine or thebaine structure possessing some affinity to any, or all, of the opioid receptor subtypes. Examples are heroin, buprenorphine and naltrexone.

• Opioid - any compound, peptide or otherwise, which, while not containing the fundamental morphine or thebaine structure, possesses some affinity for any, or all, of the opioid receptor subtypes. Common opioids are endorphin, fentanyl and methadone.

• Partial agonist - a compound which possesses affinity for a receptor, but unlike a full agonist, will elicit only a small degree of the pharmacological response peculiar to the nature of the receptor involved, even if a high proportion of receptors are occupied by the compound.

• Pharmacophore - the minimum functionality, or 3-D configuration of specific atoms or groups, that a molecule must have in order to exhibit biological activity.

• Selectivity - the relationship between the affinity of a compound for a particular receptor and its affinity for other types of opioid receptor. For instance, a compound that will bind with high affinity to the mu-receptors, but with very low affinity to kappa and delta receptors, is said to possess high selectivity for mu.

• Semi-synthetic opiate/opioid - a compound with some opioid receptor affinity, synthesized by functional modification of a product extracted from opium.

• Synthetic opiate/opioid - a compound with some opioid receptor affinity, synthesized using no products extracted from opium.

The information contained in Advanced Pain Treatment’s website is intended as an educational aid only.

• It is not intended as medical advice for individual conditions or treatment.
• It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals.

Talk to your doctor or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor or pharmacist can provide you with advice on what is safe and effective for you.

Advanced Pain Treatment is not responsible for application of any information provided in its website. By use of this website user agrees to hold Advanced Pain Treatment harmless in any legal action regarding use, interpretation or application of this website’s information.

Visit National Library of Medicine Drug Information © 2005 National Library of Medicine (NLM) & National Institutes of Health (NIH)